Andrzej Jakubowiak to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Antineoplastic Agents, Immunological.
Connection Strength
0.739
-
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood Cancer J. 2021 05 26; 11(5):103.
Score: 0.551
-
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent. Adv Ther. 2026 01; 43(1):333-355.
Score: 0.188